Zobrazeno 1 - 10
of 164
pro vyhledávání: '"S. L. Jeffcoate"'
Autor:
S. L. Jeffcoate
Publikováno v:
Diabetic Medicine. 21:657-665
The long-term complications of diabetes have major consequences for individual subjects and growing healthcare delivery and cost implications for society. Evidence for the benefits of good glycaemic control, as monitored by glycated haemoglobin measu
Publikováno v:
Journal of Clinical Pathology. 55:729-733
This article describes a new set of revised standards for the medical laboratory, which have been produced by Clinical Pathology Accreditation (UK) Ltd (CPA). The original standards have been in use since 1992 and it was recognised that extensive rev
Publikováno v:
Proceedings of the Royal Society of Edinburgh. Section B. Biological Sciences. 101:207-226
SynopsisAssuring the quality, safety and efficacy of the complex medicinal drugs known as ‘biologicals’ has many facets of importance to public health. This survey covers the historical basis of this area of medical science through current issues
Autor:
S. L. Jeffcoate
Publikováno v:
Clinical Endocrinology. 46:527-529
Autor:
S L, Jeffcoate
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 21(7)
The long-term complications of diabetes have major consequences for individual subjects and growing healthcare delivery and cost implications for society. Evidence for the benefits of good glycaemic control, as monitored by glycated haemoglobin measu
Autor:
S L, Jeffcoate
Publikováno v:
Developments in biological standardization. 100
Autor:
S L, Jeffcoate
Publikováno v:
Clinical endocrinology. 46(5)
Publikováno v:
Growth regulation. 5(3)
Following an earlier decision to move away from the in vivo bioassay for determination of the potency of therapeutic somatropin (recombinant DNA human growth hormone), 18 laboratories in 12 countries participated in an international collaborative stu
Autor:
S L, Jeffcoate
Publikováno v:
Developments in biological standardization. 83
Although the need is diminishing, biological assays still have an important place in the characterization and quality control of therapeutic peptides prepared by recombinant DNA technology. This role needs to be assessed on a case-by-case, product-by